Tomas Orozco - 06 Mar 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
EVP, Consumer Care
Signature
/s/ Eric Halverson for Tomas Orozco, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
06 Mar 2025
Net transactions value
$0
Form type
4
Filing time
10 Mar 2025, 20:35:06 UTC
Previous filing
08 Jan 2025
Next filing
11 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise +2,491 +32% 10,321 06 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -2,491 -50% $0.000000 2,490 06 Mar 2025 Common Stock 2,491 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These restricted stock units vest in three equal annual installments beginning on March 6, 2024.